US EditionFirst Cancer Trial Targeting “Undruggable” MYC Launching
Summary by Inside Precision Medicine
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
First Cancer Trial Targeting “Undruggable” MYC Launching
“A world-first” clinical trial targeting currently undruggable cancers will begin later this year led by a research team from The Australian National University (ANU) and Canberra Health Services. The trial targets MYC-driven cancers—including prostate, breast, ovarian, and hematological malignancies. MYC is a key regulator of cell growth. The drug being tested is PMR-116. “Approximately 70 per cent of all cancers are fueled by abnormal MYC acti…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
